Intestinal trefoil factor

Drug Profile

Intestinal trefoil factor

Alternative Names: hITF protein; rhITF; TFF3; Trefoil factor 3 protein; Trefoil factor family 3 peptide

Latest Information Update: 11 Aug 2015

Price : $50

At a glance

  • Originator The GI Company
  • Class Antiulcers; Cytoprotectives; Peptides
  • Mechanism of Action Mucoprotein stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes
  • Available For Licensing Yes - Stomatitis

Highest Development Phases

  • No development reported Corneal injuries; NSAID-induced ulcer; Stomatitis; Ulcerative colitis

Most Recent Events

  • 06 Nov 2008 Intestinal trefoil factor is available for licensing (http://www.thegicompany.com)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top